Evaluation of the Feasibility and Efficacy of Point-of-care Antibody Tests for Biomarker Guided Management of COVID-19.
Cavan Reilly,Eleftherios Mylonakis,Robin Dewar,Barnaby Young,Jacqueline Nordwall,Sanjay Bhagani,Po-Ying Chia, Ruby Davis,Clark Files,Adit A Ginde,Timothy Hatlen,Marie Helleberg,Awori Hayanga,Tomas O Jensen,Mamta K Jain,Ioannis Kalomenidis,Kami Kim,Perrine Lallemand,Birgitte Lindegaard, Anupama Menon, Katherine Ognenovska,Garyfallia Poulakou,Birgit Thorup Røge,Angela J Rogers,Katy Shaw-Saliba,Uriel Sandkovsky,Barbara W Trautner, Shikha S Vasudeva,Andrew Vekstein, Kimberley Viens, James Wyncoll,Brian DuChateau, Zhenxing Zhang,Shujiang Wu,Abdel G Babiker,Victoria Davey,Annetine Gelijns,Elizabeth Higgs,Virginia Kan,Jens Lundgren,Gail V Matthews, H Cliff Lane The Journal of infectious diseases（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper